Fendi Setiawan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Fendi Setiawan has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Andi Setiawan
Department of Chemistry, Faculty of Sciences, Lampung University, Bandar Lampung 35145, Indonesia
7 shared publications - Wawan Abdullah Setiawan
Department of Biology, Faculty of Mathematics and Natural Science, Lampung University, Bandar Lampung 35145, Indonesia
6 shared publications - Peni Ahmadi
BRIN.
5 shared publications - John Hendri
Department of Chemistry, Faculty of Sciences, Lampung University, Bandar Lampung 35145, Indonesia
4 shared publications - Masayoshi Arai
Graduate School of Pharmaceutical Sciences, The University of Osaka, 1–6 Yamadaoka, Suita, Osaka 565–0871, Japan
4 shared publications - Widyastuti Widyastuti
Department of Chemistry, Faculty of Sciences, Lampung University, Bandar Lampung 35145, Indonesia
4 shared publications
Latest Publications
- 12 August 2026
- Published by Elsevier in Fitoterapia
- Vol. 194
Substrate-dependent metabolites from mangrove-derived Aspergillus ochraceus PLP1F21 exhibit antibacterial and wound healing activities
- 12 August 2026
- Published by Elsevier in Fitoterapia
- Vol. 194
Substrate-dependent metabolites from mangrove-derived Aspergillus ochraceus PLP1F21 exhibit antibacterial and wound healing activities
- Open Access
- 25 June 2026
- Published by Pandawa Institute in Journal of Multidisciplinary Applied Natural Science
- Vol. 6 (3) , 1388-1408
Shrimp Shell-Based Solid-State Fermentation Promotes Dual Antibacterial and Cytotoxic Metabolite in Kocuria palustris 19C38A1
The growing impact of antimicrobial resistance (AMR) and cancer highlights the need to develop new and more effective therapeutic agents. Here, we explore a solid-state fermentation (SSF) strategy using shrimp-shell waste to stimulate secondary metabolite of marine Kocuria palustris 19C38A1. Bioautography-guided screening revealed that polar components of the extract (C38FA) showed antibacterial activity against multidrug-resistant Staphylococcus aureus (MIC = 250 µg/mL), The same fraction demonstrated pronounced cytotoxicity, inhibiting cell viability of A549 and HeLa cancer cells by 89% and 98%, respectively, at 100 μg mL-1 concentration, while showing weaker activity toward MCF-7 cells. Dereplication analysis using LC–MS/MS has annotated six putative metabolites such as terpendole B (1), p-hydroxyphenylacetylglutamic acid (2), istamycin C1 (3), lankacidin C (4), anthelmycin (5), and octacosa-hexaenoic acid (6) with mass accuracies within ±0.3 ppm. Notably, four of these compounds have well established antibacterial or cytotoxic properties, consistent with the dual in vitro bioactivity observed. ADME predictions suggested that compounds 1 and 2 are the most promising drug-like candidates, showing high gastrointestinal absorption and low cytochrome P450 liability. Furthermore, computational target prediction indicated potential interactions with proteases, kinases, oxidoreductases, and EGFR associated pathways, further hinting at their dual activity multifunctionality. Molecular docking suggested that compound 1 binds to FtsZ and EGFR, with predicted binding energies of -6.89 and -9.03 kcal/mol, respectively. Collectively, this work suggests that shrimp-shell waste can serve as a sustainable biogenic elicitor that induces marine actinobacteria to produce metabolites with dual pharmacological activities under SSF. These findings highlight a sustainable method for discovering potential dual activity antibacterial and anticancer bioactive compounds with therapeutic potential.
- 25 June 2026
- Published by Pandawa Institute in Journal of Multidisciplinary Applied Natural Science
- Vol. 6 (3) , 1388-1408
Open AccessShrimp Shell-Based Solid-State Fermentation Promotes Dual Antibacterial and Cytotoxic Metabolite in Kocuria palustris 19C38A1
The growing impact of antimicrobial resistance (AMR) and cancer highlights the need to develop new and more effective therapeutic agents. Here, we explore a solid-state fermentation (SSF) strategy using shrimp-shell waste to stimulate secondary metabolite of marine Kocuria palustris 19C38A1. Bioautography-guided screening revealed that polar components of the extract (C38FA) showed antibacterial activity against multidrug-resistant Staphylococcus aureus (MIC = 250 µg/mL), The same fraction demonstrated pronounced cytotoxicity, inhibiting cell viability of A549 and HeLa cancer cells by 89% and 98%, respectively, at 100 μg mL-1 concentration, while showing weaker activity toward MCF-7 cells. Dereplication analysis using LC–MS/MS has annotated six putative metabolites such as terpendole B (1), p-hydroxyphenylacetylglutamic acid (2), istamycin C1 (3), lankacidin C (4), anthelmycin (5), and octacosa-hexaenoic acid (6) with mass accuracies within ±0.3 ppm. Notably, four of these compounds have well established antibacterial or cytotoxic properties, consistent with the dual in vitro bioactivity observed. ADME predictions suggested that compounds 1 and 2 are the most promising drug-like candidates, showing high gastrointestinal absorption and low cytochrome P450 liability. Furthermore, computational target prediction indicated potential interactions with proteases, kinases, oxidoreductases, and EGFR associated pathways, further hinting at their dual activity multifunctionality. Molecular docking suggested that compound 1 binds to FtsZ and EGFR, with predicted binding energies of -6.89 and -9.03 kcal/mol, respectively. Collectively, this work suggests that shrimp-shell waste can serve as a sustainable biogenic elicitor that induces marine actinobacteria to produce metabolites with dual pharmacological activities under SSF. These findings highlight a sustainable method for discovering potential dual activity antibacterial and anticancer bioactive compounds with therapeutic potential.
- Open Access
- 4 June 2026
- Published by Pandawa Institute in Journal of Multidisciplinary Applied Natural Science
- Vol. 6 (3) , 1324-1349
OSMAC-Activated Alkaloid Diversity in a Mangrove Aspergillus sp. PLP1-F1 Drives Host-Directed Antibacterial Mechanisms
The growing threat of multidrug-resistant (MDR) pathogens such as Staphylococcus aureus and Pseudomonas aeruginosa necessitates discovery strategies that move beyond conventional single-target antibiotics. Here, we report a dereplication-guided pipeline applied to the mangrove-derived fungus Aspergillus sp. PLP1-F1, cultivated under an one strain–many compounds (OSMAC) solid-state fermentation using agro-industrial waste substrates to activate cryptic biosynthetic pathways. Molecular networking revealed 24 compounds with diverse chemical structures, including spiro-γ-dilactone, chinulin, anthraquinoline, notoamides, epi-fiscalins, okaramines, aspergillides, and cinatrins. The fungal extract exhibited potent antibacterial against resistant pathogen with a minimum inhibition concentration (MIC) of 250 µg/mL. To support these findings, pharmacokinetic profiling (ADME) identified 13 metabolites with favorable drug-likeness properties. Molecular docking against the bacterial division protein FtsZ highlighted three lead candidates epi-fiscalin C (16) (-8.89 kcal/mol), notoamide A (20) (-9.05 kcal/mol), and notoamide O (21) (-8.52 kcal/mol) with superior binding affinities compared to ciprofloxacin (-8.23 kcal/mol), suggesting interference with bacterial cytokinesis. Protein–protein interaction analyses further demonstrated that these alkaloids modulate host signaling networks, including EGFR–MAPK, PI3K–mTOR, caspase-mediated apoptosis, and matrix metalloproteinases. Functional enrichment additionally implicated IL‑17 signaling and neutrophil extracellular trap formation, pathways central to antibacterial immunity and inflammation control. Notably, FtsZ was not a central hub within the interaction networks, indicating that direct bacterial inhibition likely functions as a supportive mechanism alongside host-directed effects. Collectively this study underscores the value of OSMAC-driven metabolomics and systems pharmacology in accelerating natural product discovery, offering a scalable framework for identifying marine fungal metabolites with complex, resistance-resilient mechanisms of action.
- 4 June 2026
- Published by Pandawa Institute in Journal of Multidisciplinary Applied Natural Science
- Vol. 6 (3) , 1324-1349
Open AccessOSMAC-Activated Alkaloid Diversity in a Mangrove Aspergillus sp. PLP1-F1 Drives Host-Directed Antibacterial Mechanisms
The growing threat of multidrug-resistant (MDR) pathogens such as Staphylococcus aureus and Pseudomonas aeruginosa necessitates discovery strategies that move beyond conventional single-target antibiotics. Here, we report a dereplication-guided pipeline applied to the mangrove-derived fungus Aspergillus sp. PLP1-F1, cultivated under an one strain–many compounds (OSMAC) solid-state fermentation using agro-industrial waste substrates to activate cryptic biosynthetic pathways. Molecular networking revealed 24 compounds with diverse chemical structures, including spiro-γ-dilactone, chinulin, anthraquinoline, notoamides, epi-fiscalins, okaramines, aspergillides, and cinatrins. The fungal extract exhibited potent antibacterial against resistant pathogen with a minimum inhibition concentration (MIC) of 250 µg/mL. To support these findings, pharmacokinetic profiling (ADME) identified 13 metabolites with favorable drug-likeness properties. Molecular docking against the bacterial division protein FtsZ highlighted three lead candidates epi-fiscalin C (16) (-8.89 kcal/mol), notoamide A (20) (-9.05 kcal/mol), and notoamide O (21) (-8.52 kcal/mol) with superior binding affinities compared to ciprofloxacin (-8.23 kcal/mol), suggesting interference with bacterial cytokinesis. Protein–protein interaction analyses further demonstrated that these alkaloids modulate host signaling networks, including EGFR–MAPK, PI3K–mTOR, caspase-mediated apoptosis, and matrix metalloproteinases. Functional enrichment additionally implicated IL‑17 signaling and neutrophil extracellular trap formation, pathways central to antibacterial immunity and inflammation control. Notably, FtsZ was not a central hub within the interaction networks, indicating that direct bacterial inhibition likely functions as a supportive mechanism alongside host-directed effects. Collectively this study underscores the value of OSMAC-driven metabolomics and systems pharmacology in accelerating natural product discovery, offering a scalable framework for identifying marine fungal metabolites with complex, resistance-resilient mechanisms of action.
- 7 May 2026
- Published by Bentham Science Publishers Ltd. in Mini-Reviews in Medicinal Chemistry
- Vol. 26
Cosmeceutical Potential of Marine Sponge Metabolites
Marine sponges are among the richest sources of bioactive compounds, boasting a wide variety of secondary metabolites with promising potential for use in cosmeceutical products. There are 71 compounds, including alkaloids, terpenoids, peptides, sterols, and fatty acids, with a range of biological activities beneficial for skin health and beauty care. With the growing trend toward incorporating marine-derived bioactive ingredients, cosmetic formulations increasingly focus on natural compounds that have demonstrated positive effects on skin appearance and wellness. This review explores the potential of marine sponges as a valuable source of these bioactive compounds, highlights recent discoveries and their mechanisms of action, and discusses the current challenges and prospects for developing marine sponge-derived ingredients into effective cosmetic products.
- 7 May 2026
- Published by Bentham Science Publishers Ltd. in Mini-Reviews in Medicinal Chemistry
- Vol. 26
Cosmeceutical Potential of Marine Sponge Metabolites
Marine sponges are among the richest sources of bioactive compounds, boasting a wide variety of secondary metabolites with promising potential for use in cosmeceutical products. There are 71 compounds, including alkaloids, terpenoids, peptides, sterols, and fatty acids, with a range of biological activities beneficial for skin health and beauty care. With the growing trend toward incorporating marine-derived bioactive ingredients, cosmetic formulations increasingly focus on natural compounds that have demonstrated positive effects on skin appearance and wellness. This review explores the potential of marine sponges as a valuable source of these bioactive compounds, highlights recent discoveries and their mechanisms of action, and discusses the current challenges and prospects for developing marine sponge-derived ingredients into effective cosmetic products.
- Open Access
- 22 December 2024
- Published by Pandawa Institute in Journal of Multidisciplinary Applied Natural Science
- Vol. 5 (1) , 184-199
Chemical Profile of The Ethyl Acetate Extract of Aspergillus sydowi, 22-PLP1-F1, as Antibacterial Agent Against Clinically Resistant Strains of Staphylococcus aureus and Pseudomonas aeruginosa
Mangrove endophytic fungi can produce bioactive substances with diverse biological functions. This study aims to evaluate the chemical profile of mangrove fungal endophytic extracts that inhibit clinical pathogenic bacteria resistant to various antibiotics. The fungi were collected from Petengoran mangrove forest, Lampung Province. Fungal isolates were grown on shrimp shell media using solid-state fermentation for 14 days. The fungal biomass was extracted using ethyl acetate, and the active components were evaluated using thin layer chromatography. The extract was partitioned with dichloromethane/water and its bioactivity was tested using TLC-bioautography and agar diffusion methods. The active fraction was identified using LC-MS/MS. The LC-MS/MS data was interpreted with SIRIUS 5.8.6, and the drug-likeness and toxicological characteristics were assessed using ADME/Tox and STopTox machine learning tools. Morphological analysis showed that isolate 22PLP1F1 was an Aspergillus sp., with spherical conidia at the hyphae tips. Through phylogenetic analysis it was confirmed that isolate 22PLP1F1 is Aspergillus sydowii with similarity 98.9%. Initial TLC examination indicated the production of alkaloids, polypeptides, and steroids. Antibacterial assays showed that the polar portion inhibited multi-drug resistance (MDR) Staphylococcus aureus, while the active fraction at 2 mg/mL inhibited MDR Pseudomonas aeruginosa. LC-MS/MS analysis revealed a major chromatogram peak at a retention time of 8.67; m/z 488.2196, suggesting a novel derivative of a compound at a retention time of 7.82; m/z 446.208. ADME/Tox analysis indicated that the compounds do not penetrate the BBB but remain in the GI absorption region. Further research is needed to elucidate the active compounds’ mechanism of action and conduct bioengineering studies.
- 22 December 2024
- Published by Pandawa Institute in Journal of Multidisciplinary Applied Natural Science
- Vol. 5 (1) , 184-199
Open AccessChemical Profile of The Ethyl Acetate Extract of Aspergillus sydowi, 22-PLP1-F1, as Antibacterial Agent Against Clinically Resistant Strains of Staphylococcus aureus and Pseudomonas aeruginosa
Mangrove endophytic fungi can produce bioactive substances with diverse biological functions. This study aims to evaluate the chemical profile of mangrove fungal endophytic extracts that inhibit clinical pathogenic bacteria resistant to various antibiotics. The fungi were collected from Petengoran mangrove forest, Lampung Province. Fungal isolates were grown on shrimp shell media using solid-state fermentation for 14 days. The fungal biomass was extracted using ethyl acetate, and the active components were evaluated using thin layer chromatography. The extract was partitioned with dichloromethane/water and its bioactivity was tested using TLC-bioautography and agar diffusion methods. The active fraction was identified using LC-MS/MS. The LC-MS/MS data was interpreted with SIRIUS 5.8.6, and the drug-likeness and toxicological characteristics were assessed using ADME/Tox and STopTox machine learning tools. Morphological analysis showed that isolate 22PLP1F1 was an Aspergillus sp., with spherical conidia at the hyphae tips. Through phylogenetic analysis it was confirmed that isolate 22PLP1F1 is Aspergillus sydowii with similarity 98.9%. Initial TLC examination indicated the production of alkaloids, polypeptides, and steroids. Antibacterial assays showed that the polar portion inhibited multi-drug resistance (MDR) Staphylococcus aureus, while the active fraction at 2 mg/mL inhibited MDR Pseudomonas aeruginosa. LC-MS/MS analysis revealed a major chromatogram peak at a retention time of 8.67; m/z 488.2196, suggesting a novel derivative of a compound at a retention time of 7.82; m/z 446.208. ADME/Tox analysis indicated that the compounds do not penetrate the BBB but remain in the GI absorption region. Further research is needed to elucidate the active compounds’ mechanism of action and conduct bioengineering studies.
- Open Access
- 28 March 2023
- Published by MDPI AG in Fermentation
- Vol. 9 (4) , 334
Exploration and Biorefinery Antimicrobial Agent through Solid State Fermentation from Indonesia’s Marine Actinomycetes
This study aimed to obtain novel bioactive compounds derived from actinomycetes associated with marine biota from the coast of Indonesia. Actinomycetes have been identified as a potential source of bioactive compounds through enzymatic fermentation. In order to obtain bioactive compounds from the results of the biorefinery process, cultivation was performed by solid state fermentation (SSF) on shrimp shell waste medium. The inhibitory activity against pathogenic microorganisms was measured based on the optical density of samples from Gorontalo and Buleleng, Bali, Indonesia. Six isolates had a clear zone as an indicator of the chitinase activity of chitinase enzymes. The SSF extract, obtained after 14 days of incubation, was assayed for its antimicrobial activity by the 96-well plate microtiter method. Among the six isolates, isolate 19B19A1 had antibacterial and antifungal activity against Staphylococcus aureus and Malassezia globosa, respectively. DNA analysis indicated that the 19B19A1 isolate was Streptomyces tritolerans 19B19A1 and that its extract contained an alkaloid component that played a role in antimicrobial activity. These results indicate that shrimp shells can be used as a nutrient-rich alternative culture medium for actinomycetes. This study is expected to become a source of information related to biorefinery, especially in the exploration of bioactive compounds produced by actinomycetes.
- 28 March 2023
- Published by MDPI AG in Fermentation
- Vol. 9 (4) , 334
Open AccessExploration and Biorefinery Antimicrobial Agent through Solid State Fermentation from Indonesia’s Marine Actinomycetes
This study aimed to obtain novel bioactive compounds derived from actinomycetes associated with marine biota from the coast of Indonesia. Actinomycetes have been identified as a potential source of bioactive compounds through enzymatic fermentation. In order to obtain bioactive compounds from the results of the biorefinery process, cultivation was performed by solid state fermentation (SSF) on shrimp shell waste medium. The inhibitory activity against pathogenic microorganisms was measured based on the optical density of samples from Gorontalo and Buleleng, Bali, Indonesia. Six isolates had a clear zone as an indicator of the chitinase activity of chitinase enzymes. The SSF extract, obtained after 14 days of incubation, was assayed for its antimicrobial activity by the 96-well plate microtiter method. Among the six isolates, isolate 19B19A1 had antibacterial and antifungal activity against Staphylococcus aureus and Malassezia globosa, respectively. DNA analysis indicated that the 19B19A1 isolate was Streptomyces tritolerans 19B19A1 and that its extract contained an alkaloid component that played a role in antimicrobial activity. These results indicate that shrimp shells can be used as a nutrient-rich alternative culture medium for actinomycetes. This study is expected to become a source of information related to biorefinery, especially in the exploration of bioactive compounds produced by actinomycetes.
- Open Access
- 26 July 2022
- Published by MDPI AG in Fermentation
- Vol. 8 (8) , 353
Antifungal Agent Chitooligosaccharides Derived from Solid-State Fermentation of Shrimp Shell Waste by Pseudonocardia antitumoralis 18D36-A1
Shrimp shell waste is a potential source of the biopolymer chitin. Through fermentation, chitin can be converted into its derivative products. This study aimed to isolate and characterize the products of the biodegradation of chitin from shrimp shell waste through a solid-state fermentation process using actinomycetes. Actinomycete isolates were obtained from tunicate marine biota collected from the waters of Buleleng, Bali, using a dilution technique on 1% chitin colloid agar medium. The isolated actinomycetes were cultivated on a shrimp shell waste medium for 7 days, and then the products of the biodegradation of the oligomers were extracted using water. The extracts of the biodegradation products of the shrimp shells were isolated through several chromatographic steps and analyzed using LC–MS–MS, and the bioactivity of the biodegradation products against fungi was tested. The morphological observations and phylogenetic analysis showed that the isolate 18D36-A1 was a rare actinomycete with the proposed name Pseudonocardia antitumoralis 18D36-A1. The results of the analysis using TLC showed that the solid-state fermented water isolate 18D36-A1 produced several oligomeric components. These results indicate that the isolate 18D36-A1 was able to convert chitin into chitooligosaccharides. Further isolation of the extract produced the active fraction D36A1C38, which can inhibit the growth of fungi by 74% at a concentration of 1 mg/mL. This initial information is very important for further studies related to the development of a solid-state fermentation process for obtaining bioactive compounds from shrimp shell waste.
- 26 July 2022
- Published by MDPI AG in Fermentation
- Vol. 8 (8) , 353
Open AccessAntifungal Agent Chitooligosaccharides Derived from Solid-State Fermentation of Shrimp Shell Waste by Pseudonocardia antitumoralis 18D36-A1
Shrimp shell waste is a potential source of the biopolymer chitin. Through fermentation, chitin can be converted into its derivative products. This study aimed to isolate and characterize the products of the biodegradation of chitin from shrimp shell waste through a solid-state fermentation process using actinomycetes. Actinomycete isolates were obtained from tunicate marine biota collected from the waters of Buleleng, Bali, using a dilution technique on 1% chitin colloid agar medium. The isolated actinomycetes were cultivated on a shrimp shell waste medium for 7 days, and then the products of the biodegradation of the oligomers were extracted using water. The extracts of the biodegradation products of the shrimp shells were isolated through several chromatographic steps and analyzed using LC–MS–MS, and the bioactivity of the biodegradation products against fungi was tested. The morphological observations and phylogenetic analysis showed that the isolate 18D36-A1 was a rare actinomycete with the proposed name Pseudonocardia antitumoralis 18D36-A1. The results of the analysis using TLC showed that the solid-state fermented water isolate 18D36-A1 produced several oligomeric components. These results indicate that the isolate 18D36-A1 was able to convert chitin into chitooligosaccharides. Further isolation of the extract produced the active fraction D36A1C38, which can inhibit the growth of fungi by 74% at a concentration of 1 mg/mL. This initial information is very important for further studies related to the development of a solid-state fermentation process for obtaining bioactive compounds from shrimp shell waste.
- Open Access
- 9 March 2022
- Published by MDPI AG in Journal of Fungi
- Vol. 8 (3) , 280
Fungicide Activity of Culture Extract from Kocuria palustris 19C38A1 against Fusarium oxysporum
Secondary metabolites of actinomycetes are a potential source of bioactive compounds in the agricultural sector. This study aimed to determine the fungicidal properties of extracts of marine organism-derived actinomycetes. Actinomycetes were isolated from marine organisms using agar media with 1% colloidal chitin in artificial seawater. Then, the isolates were cultured on liquid media with 1% colloidal chitin in artificial seawater under static conditions for 14 days. The culture was extracted, the fungicide properties were evaluated using the microtiter 96-well plate method, and the influence of inhibition was visualized using apotome and SEM. Finally, the active extract was analyzed using LCMSMS. In the present study, 19 actinomycetes were isolated from marine organisms, and the isolates were examined with regard to their antifungal activities. Of these nineteen isolates, the isolate 19C38A1 was picked out from the rest. Hence, it showed significant control towards F. oxysporum. The prospective strain 19C38A1 was determined to be Kocuria palustris 19C38A1. The extract 19C38A1 was shown to cause damage to cell integrity, indicated by the shrinking form, and inhibited germination in the F. oxysporum; subsequently, the chemical characteristics of the compound produced by the potential isolate 19C38A1 indicated the presence of benzimidazole compounds in the active fraction of C38BK2FA. These results indicate that actinomycetes derived from marine organisms near the coast of Oluhuta, Tomini Bay, Gorontalo, related to strain 19C38A1, are not widely known as sources of valuable fungicides. This preliminary information is important, as it can be used as a basis for further development in the search for fungicides derived from marine actinomycetes.
- 9 March 2022
- Published by MDPI AG in Journal of Fungi
- Vol. 8 (3) , 280
Open AccessFungicide Activity of Culture Extract from Kocuria palustris 19C38A1 against Fusarium oxysporum
Secondary metabolites of actinomycetes are a potential source of bioactive compounds in the agricultural sector. This study aimed to determine the fungicidal properties of extracts of marine organism-derived actinomycetes. Actinomycetes were isolated from marine organisms using agar media with 1% colloidal chitin in artificial seawater. Then, the isolates were cultured on liquid media with 1% colloidal chitin in artificial seawater under static conditions for 14 days. The culture was extracted, the fungicide properties were evaluated using the microtiter 96-well plate method, and the influence of inhibition was visualized using apotome and SEM. Finally, the active extract was analyzed using LCMSMS. In the present study, 19 actinomycetes were isolated from marine organisms, and the isolates were examined with regard to their antifungal activities. Of these nineteen isolates, the isolate 19C38A1 was picked out from the rest. Hence, it showed significant control towards F. oxysporum. The prospective strain 19C38A1 was determined to be Kocuria palustris 19C38A1. The extract 19C38A1 was shown to cause damage to cell integrity, indicated by the shrinking form, and inhibited germination in the F. oxysporum; subsequently, the chemical characteristics of the compound produced by the potential isolate 19C38A1 indicated the presence of benzimidazole compounds in the active fraction of C38BK2FA. These results indicate that actinomycetes derived from marine organisms near the coast of Oluhuta, Tomini Bay, Gorontalo, related to strain 19C38A1, are not widely known as sources of valuable fungicides. This preliminary information is important, as it can be used as a basis for further development in the search for fungicides derived from marine actinomycetes.